|
|
|
|
|
|
|
Free Newsletters
Archive
My Subscriptions
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers
Regional News
US & Canada
Biotech Bay
Biotech Beach
Genetown
Pharm Country
BioCapital
BioMidwest
Bio NC
BioForest
Southern Pharm
BioCanada East
US Device
Europe
Asia
Market Summary
News
IPOs
Company Profiles
Companies
Events
Research Store
Biotech Events
Post an Event
Real Estate
Business Opportunities
|
|
|
|
|
News | News By Subject | News by Disease |
News By Date | Search News
|
|
|
GNI Ltd. And Shanghai Genomics, Inc. Merge; Japanese And Chinese Biotech Companies Combine To Increase R&D Productivity And Market Opportunity
10/19/2005 5:09:13 PM
TOKYO & SHANGHAI, China--(BUSINESS WIRE)--June 20, 2005--GNI Ltd. and Shanghai Genomics announced today that the two companies have formed a merger. GNI concurrently raised a private equity round of financing of over $13M led by Nomura, Healthcare Partners and several other U.S. and Japanese private equity firms.
The merger delivers several benefits, most notably from Shanghai Genomics' Western-quality discovery research, preclinical development, and contract research services to facilitate cost-efficient drug development, faster revenue generation and, ultimately, profitability for the united company.
|
|
|
|
|
|
|
|
|
|
|